The neutralization of TLR2 and TLR4 via anti-TLR2 and anti-TLR4 antibodies has shown to block the immune response to fibrillar Aβ(1-42) aggregates in AD models [166]. This evidence concerns the gene TLR4 and Alzheimer disease.